Skip to main content

Madelyn Zeylikman

Equibles does not estimate personal net worth.

Get an email with a short summary when Kiniksa Pharmaceuticals International, plc publishes a filing, an earnings call transcript or a press release.

Get KNSA alerts

About Madelyn Zeylikman

Madelyn Zeylikman is recorded as General Counsel at Kiniksa Pharmaceuticals International, plc (KNSA) since May 12, 2021. Kiniksa Pharmaceuticals International, plc reported in an 8-K filed May 12, 2021 that Madelyn Zeylikman was appointed General Counsel. Kiniksa Pharmaceuticals International, plc is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Kiniksa Pharmaceuticals International, plc includes Sanj K. Patel (CEO and Board Member), Mark Ragosa (CFO), Ross Moat (COO) and 7 others.

“In conjunction therewith, the company appointed Madelyn Zeylikman, the company's Vice President, Legal, to General Counsel.”
Kiniksa Pharmaceuticals International, plc Form 8-K, filed May 12, 2021 · Read the filing

Affiliation history

Company network

Leadership on record at Kiniksa Pharmaceuticals International, plc

Recent activity